Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuroimaging of Adolescent Cannabis Use Treatment

NCT: NCT07340554 · RECRUITING

NCT IDNCT07340554
StatusRECRUITING
Start Date2026-06
Completion2030-05

Brief Summary

This study is testing whether brain activity related to learning can help predict how well teens respond to a treatment program designed to reduce cannabis use. Teens ages 14-17 will complete a brain scan and then take part in 10 weekly virtual sessions where they report cannabis use and complete drug tests at home. Participants can earn prizes for staying cannabis-free.

Frequently Asked Questions

What is Neuroimaging of Adolescent Cannabis Use Treatment?

Neuroimaging of Adolescent Cannabis Use Treatment is a clinical trial registered under NCT07340554. Current status: RECRUITING.

What is the status of NCT07340554?

The current status of NCT07340554 (Neuroimaging of Adolescent Cannabis Use Treatment) is: RECRUITING.

When did Neuroimaging of Adolescent Cannabis Use Treatment start?

Neuroimaging of Adolescent Cannabis Use Treatment started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.